Global Procurement Director of Solutions Excellence & User Experience
Gilead Sciences- Full Time
- Senior (5 to 8 years)
Apogee Therapeutics, Inc. is a well-funded, Nasdaq-listed biotechnology company founded in 2022. We are seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications with high unmet need. Our antibody programs aim to improve upon existing therapies by targeting well-established mechanisms of action and utilizing advanced antibody engineering. We are committed to reshaping the standard of care for inflammatory and immune diseases, driven by our belief that patients deserve the best possible treatment. Our company culture is built on C.O.R.E. values: Caring, Original, Resilient, and Egoless.
This newly created position will lead Apogee’s strategic sourcing and procurement efforts as the company grows. Reporting to the SVP of Finance, this role offers the opportunity to establish and build this critical function. A key aspect of this role is to build and manage long-term, mutually beneficial vendor relationships that drive value and support the company's mission. You will act as a strategic partner with functional business partners, particularly in clinical development, clinical operations, and manufacturing, to manage supplier selection, contract negotiation, and enforcement of terms.
Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics, Inc. is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications with high unmet need. Our antibody programs are designed to potentially overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. We seek to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment, and we refuse to stop at “good enough.” We are a fast-paced company committed to building an exceptional company culture, founded on our C.O.R.E. values: Caring, Original, Resilient and Egoless.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.